0002107396-26-000002.txt : 20260204 0002107396-26-000002.hdr.sgml : 20260204 20260204143123 ACCESSION NUMBER: 0002107396-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260204 DATE AS OF CHANGE: 20260204 EFFECTIVENESS DATE: 20260204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gilgamesh Pharma Inc. CENTRAL INDEX KEY: 0002107396 ORGANIZATION NAME: EIN: 393989868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-572361 FILM NUMBER: 26597527 BUSINESS ADDRESS: STREET 1: 113 UNIVERSITY PLACE, SUITE 1019 CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 929-723-4861 MAIL ADDRESS: STREET 1: 113 UNIVERSITY PLACE, SUITE 1019 CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0708 D LIVE 0002107396 Gilgamesh Pharma Inc. 113 UNIVERSITY PLACE, SUITE 1019 NEW YORK NY NEW YORK 10003 929-723-4861 DELAWARE None None Corporation true 2025 Jonathan Sporn 113 UNIVERSITY PLACE, SUITE 1019 NEW YORK NY NEW YORK 10003 Executive Officer Director Andrew Kruegel 113 UNIVERSITY PLACE, SUITE 1019 NEW YORK NY NEW YORK 10003 Executive Officer Director Amy Kruse 113 UNIVERSITY PLACE, SUITE 1019 NEW YORK NY NEW YORK 10003 Director Zia Huque 113 UNIVERSITY PLACE, SUITE 1019 NEW YORK NY NEW YORK 10003 Director Phil Skolnick 113 UNIVERSITY PLACE, SUITE 1019 NEW YORK NY NEW YORK 10003 Director Robert Berman 113 UNIVERSITY PLACE, SUITE 1019 NEW YORK NY NEW YORK 10003 Director Pharmaceuticals Decline to Disclose 06b false 2026-01-02 false true false 27597 6090946 6090946 0 false 9 0 0 0 false Gilgamesh Pharma Inc. Jonathan Sporn /s/ Jonathan Sporn CEO 2026-02-04